•  
  •  
  •  
  •  

2025-08-08 18:06:56

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • BSE Ltd reports consolidated PAT of Rs. 539.41 crores in Q1 FY2026
  • Best Agrolife Ltd posts consolidated profit of Rs. 19.92 crores in Q1 FY2025-26
  • NBCC India Ltd Q1FY26 consolidated PAT at Rs. 132.12 crores
  • Godrej Consumer Products Ltd reports consolidated PAT of Rs. 452.45 crores in Q1 FY2026
  • National Aluminium Company Ltd consolidated Q1 FY2026 net profit at Rs. 1049.48 crores

Keywords Selected:  USFDA

Stock Report

  • Senores Pharmaceuticals Ltd's material subsidiary reeceives 3 observations from USFDA for its facility
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg
  • Lupin receives US FDA Approvals for Liraglutide and Glucagon Injectable Products
  • Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
  • Lupin receives Form 483 with 3 observations from USFDA for Pithampur Unit-3
  • Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™
  • Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
  • Emcure Pharmaceuticals Ltd successfully completes USFDA PAI of Oncology facility
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
  • Lupin launches Prucalopride tablets in the United States
  • SMS Pharmaceuticals Ltd successfully completes USFDA inspection at Central Laboratory Analytical Services
  • Lupin receives approval from U.S. FDA for Prucalopride Tablets
  • J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Granules India Ltd receives Form 483 with 1 observation from USFDA for Bonthapally API unit 1
  • NATCO Pharma Ltd announces conclusion of USFDA inspection at Pharma Division, Kothur

Latest Post

  • BSE Ltd reports consolidated PAT of Rs. 539.41 crores in Q1 FY2026
  • Best Agrolife Ltd posts consolidated profit of Rs. 19.92 crores in Q1 FY2025-26
  • NBCC India Ltd Q1FY26 consolidated PAT at Rs. 132.12 crores
  • Godrej Consumer Products Ltd reports consolidated PAT of Rs. 452.45 crores in Q1 FY2026
  • National Aluminium Company Ltd consolidated Q1 FY2026 net profit at Rs. 1049.48 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024